Blog

The Buzz, Issue #6 is now available, featuring five new publications with high clinical relevance for Canadian allergists.

The Buzz Issue #6, August edition, will be sent to all HIVE members by email on Monday, July 26, and can be accessed online here. This edition covers: Seroconversion following vaccination for patients on anti-CD20 therapy Association between meconium metabolome and atopy in Canadian infants Context for a network meta-analysis of antihistamines in chronic spontaneous … Continue reading The Buzz, Issue #6 is now available, featuring five new publications with high clinical relevance for Canadian allergists.

The Buzz, Issue #5 is now available! In this issue, we highlight new publications in urticaria, angioedema, asthma and draw attention to the new food allergy guidelines for childcare centres and schools.

The Buzz Issue #5, July edition, was sent to all HIVE members by email on Monday, June 28, and can be accessed online here. This edition covers: Urticaria disease activity during and after pregnancy A practical approach to identifying angioedema and urticaria mimics Conditional recommendations on the prevention and management of allergic reactions in schools … Continue reading The Buzz, Issue #5 is now available! In this issue, we highlight new publications in urticaria, angioedema, asthma and draw attention to the new food allergy guidelines for childcare centres and schools.

The Buzz, Issue #4 is now available! In this issue, we have five new articles to bring to the attention of Canadian allergists.

The Buzz Issue #4, June edition, was sent to all HIVE members by email on Monday, May 31, and can be accessed online here. This edition covers: Pathogenic differentiation of CHA and CSU Considerations for proceeding with or delaying the COViD-19 mRNA vaccine booster following a suspected anaphylactic event Case reports of omalizumab exposure in … Continue reading The Buzz, Issue #4 is now available! In this issue, we have five new articles to bring to the attention of Canadian allergists.

The Buzz, Issue #3 is now available! In this issue, we highlight 5 new articles clinically relevant for Canadian allergists.

The Buzz Issue #3, May edition, was sent to all HIVE members by email on Monday, May 3, and can be accessed online here. This edition covers: Evidence review in pediatric chronic spontaneous urticaria An allergists guide to biologic economic analyses Practical consensus recommendations for implementing oral immunotherapy Updated contact dermatitis patch test results Humoral … Continue reading The Buzz, Issue #3 is now available! In this issue, we highlight 5 new articles clinically relevant for Canadian allergists.

The Buzz, Issue #2 is now available! Check out this month’s selection of new publications clinically relevant to Canadian allergists, immunologists and dermatologists.

The Buzz Issue #2, April edition, was sent to all HIVE members by email on Monday, March 29, and can be accessed online here. This edition covers: The allergists’ perspective on anaphylaxis risk with SARS-CoV-2 vaccines Emerging biologics for chronic spontaneous urticaria Predictors of response and non-response in chronic spontaneous urticaria Real-world analysis of omalizumab … Continue reading The Buzz, Issue #2 is now available! Check out this month’s selection of new publications clinically relevant to Canadian allergists, immunologists and dermatologists.

Introducing “The Buzz”, a monthly feature of the HIVE community where recent articles are selected and summarized for clinical relevance to Canadian allergists, immunologists and dermatologists

We’re delighted to introduce a new feature of the HIVE community – The Buzz! The Buzz is a monthly selection of new publications clinically relevant to the HIVE community of Canadian allergists, immunologists and dermatologists. The Buzz will be sent to all HIVE members by email each month, with highlights in the weekly HIVE email … Continue reading Introducing “The Buzz”, a monthly feature of the HIVE community where recent articles are selected and summarized for clinical relevance to Canadian allergists, immunologists and dermatologists

You are invited: HIVE Webinar with Dr. Gordon Sussman, Thursday, June 25 at 7:00AM EST on “Chronic Urticaria: New Understanding of an Old Disease”

EVENT: HIVE webinar #1 with Dr. Gordon Sussman DATE/TIME: Thursday, June 25th at 07:00AM EST TITLE: Chronic Urticaria: New Understanding of an Old Disease LEARNING OBJECTIVES: To review clinical presentation and differential diagnosis To update new guideline in chronic urticaria To update new understanding in pathophysiology To update new treatment in chronic urticaria MEETING ACCESS: … Continue reading You are invited: HIVE Webinar with Dr. Gordon Sussman, Thursday, June 25 at 7:00AM EST on “Chronic Urticaria: New Understanding of an Old Disease”

Biologic Survey During COVID-19 Pandemic (by Drs. Waserman and Lima)

By Dr. Susan Waserman & Dr. Hermenio Lima – Calling all Allergists/Clinical Immunologists and Dermatologists! We want to hear your voice. Please take our survey on how you managed your patients on biologic therapies during the COVID 19 pandemic. It will take 2 minutes, and provide valuable information on our practice during this unprecedented time! … Continue reading Biologic Survey During COVID-19 Pandemic (by Drs. Waserman and Lima)

Dernières initiatives et développements en urticaire: Entrevue de 6 minutes avec le Docteur Jaime Del Carpio, Université McGill

>> Voir le vidéo de Dr Del Carpio Cette vidéo eXtract présente les points saillants de la conférence sur l’urticaire tenue en 2019 par les centres UCARE (Urticaria Centers of Reference and Excellence) et le réseau GA2LEN (Global Allergy and Asthma European Network). Dans ce bref survol, un expert s’attarde sur les progrès réalisés dans … Continue reading Dernières initiatives et développements en urticaire: Entrevue de 6 minutes avec le Docteur Jaime Del Carpio, Université McGill

Launch of the HIVE Community

We’re pleased to announce the launch of a new initiative called Health Innovation Virtual Engagement (HIVE), an online learning community for Canadian physicians with an interest in urticaria and related conditions. HIVE will foster open scientific discussions through online forums, webinars and micro-learning objects, to sustain ongoing connection anchored in scientific discovery and expert insight. It is our hope … Continue reading Launch of the HIVE Community